Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Using CRISPR/Cas to develop biosafety materials

Researchers discuss the use of the highly efficient CRISPR/Cas technologies to identify viral genome sequences for biosafety purposes.

21 Mar 2022

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Researchers discuss the difference between transmitters and non-transmitters of SARS-CoV-2 in terms of their mean viral load.

21 Mar 2022

Intranasal delivery of pro-resolving lipid mediators arrests memory loss in experimental Alzheimer’s model

A research collaboration between scientists at LSU Health New Orleans and the Karolinska Institutet in Sweden has found that applying specialized pro-resolving lipid mediators intranasally arrested memory loss and brain degeneration in an experimental model of Alzheimer's Disease (AD).

21 Mar 2022

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

The immune system deteriorates with age, making COVID-19 particularly deadly in older people - but to date, no clinically available medication addresses this key risk factor.

21 Mar 2022

Saliva tests detect SARS-CoV-2 virus more quickly than nasal swabs

Genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing of nasal swabs. The research is published March 21 in Microbiology Spectrum, a journal of the American Society for Microbiology.

21 Mar 2022

Coronavirus infection during pregnancy may double the risk of poor outcomes

A Kaiser Permanente analysis of pregnant patients who tested positive for the coronavirus found more than double the risk of poor outcomes including preterm birth, venous thromboembolism (blood clot), and severe maternal morbidity, which includes conditions such as acute respiratory distress syndrome and sepsis.

21 Mar 2022

Pandemic-related slowdown of cancer surgeries may impact patient survival

Pandemic-related slowdowns of cancer surgeries may result in shorter survival rates for patients with cancer, according to a new modeling study published in CMAJ.

21 Mar 2022

Study explores novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

In a new study, researchers aimed to determine if peptidyl-arginine deiminases inhibitors may be used as a novel class of host-targeting antivirals against human coronaviruses.

21 Mar 2022

Study reveals the extent of pandemic-related cancer screening deficits across the U.S.

Deaths from cancer are expected to increase over the next decade as a result of screening deficits due to the COVID-19 pandemic.

21 Mar 2022

Influence of vitamin D and age on first SARS-CoV-2 vaccine dose efficacy

Researchers illustrated that vitamin D status and age influence antibody response following the initial dose of coronavirus disease 2019 vaccination.

21 Mar 2022

Study explores decline in tuberculosis cases during COVID-19 pandemic in the United States

Researchers analyzed a pharmacy dataset to evaluate the 20% decrease in tuberculosis cases reported in 2020 by the US National Tuberculosis Surveillance System.

21 Mar 2022

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

A recent study evaluated the safety and immunogenicity of a COVID-19 vaccine in a phase II trial.

21 Mar 2022

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving remark without scientific merit. It also set off spasms of doubt over the country's objectives in its fight against the coronavirus.

21 Mar 2022

Money flows into addiction tech, but will it curb soaring opioid overdose deaths?

David Sarabia had already sold two startups by age 26 and was sitting on enough money to never have to work another day in his life.

21 Mar 2022

Study assesses human milk antibodies against common human coronaviruses following COVID-19 infection and vaccination

A recent study demonstrated that COVID-19 and its vaccination generates cross-reactive antibodies against human coronaviruses in lactating mothers.

21 Mar 2022

The importance of the endosomal pathway for SARS-CoV-2 entry

Researchers demonstrated that combined inhibition of cell-surface-based and endosomal pathways completely blocked SARS-CoV-2 entry into mammalian cells.

21 Mar 2022

Substantial alteration in gut microbiome observed in children with with MIS-C and COVID

A team of scientists from Turkey has recently evaluated the diversity and composition of gut microbiota in children diagnosed with multisystem inflammatory syndrome (MIS-C) and acute coronavirus disease 2019 (COVID-19). They have observed significant alteration in the gut microbiota composition in children with MIS-C. These changes are associated with autoimmunity, metabolic dysfunction, and obesity.

21 Mar 2022

Study links the usage of oral polio vaccines with lower incidence of COVID-19

A study published in the journal PLOS ONE showed how countries using oral polio vaccine have a lower incidence of coronavirus disease (COVID-19) when compared to those using inactivated polio vaccine – suggesting that the oral vaccine may either prevent the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the individual level or slow down the transmission in the community.

21 Mar 2022

Study unveils several natural marine products as potential agents against SARS-CoV-2

A recent study, published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy, highlighted three natural marine products as potent inhibitors of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – without any apparent toxic effects for human lung cells.

21 Mar 2022

Sex-specific differences in T-cell responses to COVID-19

Researchers evaluate both neutralizing activity and T-cell responses in SARS-CoV-2 infected individuals with mild symptoms linked to a single spreading event.

20 Mar 2022

Pandemic News and Research

Further Reading

Using CRISPR/Cas to develop biosafety materials

SARS-CoV-2 transmitters have 3 times higher viral loads than non-transmitters

Intranasal delivery of pro-resolving lipid mediators arrests memory loss in experimental Alzheimer’s model

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

Saliva tests detect SARS-CoV-2 virus more quickly than nasal swabs

Coronavirus infection during pregnancy may double the risk of poor outcomes

Pandemic-related slowdown of cancer surgeries may impact patient survival

Study explores novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

Study reveals the extent of pandemic-related cancer screening deficits across the U.S.

Influence of vitamin D and age on first SARS-CoV-2 vaccine dose efficacy

Study explores decline in tuberculosis cases during COVID-19 pandemic in the United States

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

Pfizer CEO pushes yearly shots for covid. Not so fast, experts say.

Money flows into addiction tech, but will it curb soaring opioid overdose deaths?

Study assesses human milk antibodies against common human coronaviruses following COVID-19 infection and vaccination

The importance of the endosomal pathway for SARS-CoV-2 entry

Substantial alteration in gut microbiome observed in children with with MIS-C and COVID

Study links the usage of oral polio vaccines with lower incidence of COVID-19

Study unveils several natural marine products as potential agents against SARS-CoV-2

Sex-specific differences in T-cell responses to COVID-19

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News